GlassScriptPhysician profile
Christy A Young
NPI 1528479151
$5,015.72
in general payments reported to CMS, 2019-2025
44 companies · $1,072 in 2025
The $1,072 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $762 · 2022: $1,111 · 2023: $807 · 2024: $1,264 · 2025: $1,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,143.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,258.49 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $721.04 | 2021-2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $321.42 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Takeda Pharmaceuticals U.S.A., INC. | $268.47 | 2021-2024 | Trintellix |
| Lilly USA, LLC | $198.03 | 2022-2025 | Mounjaro, Zepbound |
| Otsuka America Pharmaceutical, INC. | $177.10 | 2022-2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $172.28 | 2022-2023 | Qelbree |
| Biohaven Pharmaceuticals, INC. | $152.88 | 2021 | |
| Abbott Laboratories | $152.16 | 2024-2025 | Freestyle Libre 3 |
| Pfizer INC. | $148.80 | 2022-2025 | |
| Corium, LLC | $147.69 | 2023-2024 | Azstarys |
| Axsome Therapeutics, INC. | $128.05 | 2024-2025 | Auvelity |
| Amgen INC. | $126.16 | 2021-2025 | Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.29 | 2021-2025 | Xifaxan, Trulance |
| Tris Pharma INC | $106.53 | 2023-2025 | Dyanavel Xr |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christy Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.